SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

Category Primary study
JournalHematology, Transfusion and Cell Therapy
Year 2020
This article has no abstract
Epistemonikos ID: 40fe4bc35d69c7ac7b4cf93847b38c3983bd6cd5
First added on: Feb 12, 2025